Physician profile
Robyn A Hoffman
NPI 1275711913
$1,627.45
in general payments reported to CMS, 2019-2025
11 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $354 · 2023: $154 · 2024: $565 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $396.37 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $333.16 | 2022-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $327.06 | 2023-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Alkermes, INC. | $197.53 | 2023-2025 | Lybalvi |
| Ironshore Pharmaceuticals INC. | $129.28 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.96 | 2024 | |
| Neurocrine Biosciences, INC. | $55.82 | 2022 | |
| Corium, LLC | $42.38 | 2022 | |
| Abbott Laboratories | $34.61 | 2024-2025 | Eterna |
| Neos Therapeutics, LP | $23.42 | 2024 | Adzenys Xr-Odt |
| Tris Pharma INC | $18.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.